Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Income Before Tax

$1.54M

Quarterly · Period ending: · USD

LCTX logo

LCTX Income Before Tax

Latest reported$1.54M
LCTX Quarterly Pre-Tax Income ($0.00 → $1.54M)
High-resolution chart · PNG

LCTX income before tax history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Income Before Tax — Quarterly (USD)
Period endingIncome Before Tax (USD)
1,544,000
-4,789,000
-4,388,000
-29,752,000
-30,364,000
-4,143,000
-3,250,000
-3,001,000
-5,773,000
-6,558,000
-4,714,000
-7,158,000
-5,203,000
-6,207,000
-6,362,000
-5,575,000
-6,782,000
-7,093,000
-28,009,000
-8,846,000
-4,965,000
-1,448,000
984,000
-7,950,000
-6,530,000
-8,428,000
-5,340,000
-17,506,000
-31,300,000
34,912,000
-45,330,000
66,544,000
-4,646,000
-63,698,000
-76,844,000
18,758,000
-16,104,000
50,901,000
-7,741,000
29,265,000
21,225,000
-23,997,000
-17,926,000
-17,689,000
-13,267,000
-13,766,937
-14,976,252
-12,264,150
-12,906,966
-11,077,057
-29,335,719
-10,256,318
-8,195,613
-8,408,545
-7,151,942
-5,929,243
-5,997,617
-6,242,635
-5,465,113
-4,239,530
-4,956,548
-3,861,691
-3,598,679
-2,457,704
-2,353,687
-1,286,764
1,747,818
-2,921,091
-1,105,831
-910,187
-3,780,895
-1,077,194
-662,780
-476,048
-1,438,226
-213,491
-344,077
-553,862
-1,864,621
-340,035
0
-478,187
-410,892
-415,058
0
-726,590
-597,572
-402,542
-442,268
-1,642,942
-365,485
362,020
-752,352
-671,129
-2,277,100
0
-567,832
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.